206 related articles for article (PubMed ID: 32019724)
21. Sensitivity and specificity of cerebrospinal fluid CXCL13 for diagnosing Lyme neuroborreliosis - a study on 1410 patients and review of the literature.
Lintner H; Hochgatterer-Rechberger P; Pischinger B; Seier J; Vollmann P; Haushofer A; Rittner H; Sommer C; Topakian R
J Neurol Sci; 2020 Jul; 414():116843. PubMed ID: 32344220
[TBL] [Abstract][Full Text] [Related]
22. The relationship between the laboratory diagnosis of Lyme neuroborreliosis and climate factors in Kalmar County Sweden - an overview between 2008 and 2019.
Keith K; Årestedt K; Tjernberg I
Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):253-261. PubMed ID: 34755256
[TBL] [Abstract][Full Text] [Related]
23. CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland Å
J Neurol; 2008 May; 255(5):782. PubMed ID: 27517589
[TBL] [Abstract][Full Text] [Related]
24. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Int J Infect Dis; 2014 Nov; 28():160-3. PubMed ID: 25316329
[TBL] [Abstract][Full Text] [Related]
26. Lyme neuroborreliosis in Swedish children-PCR as a complementary diagnostic method for detection of Borrelia burgdorferi sensu lato in cerebrospinal fluid.
Skogman BH; Wilhelmsson P; Atallah S; Petersson AC; Ornstein K; Lindgren PE
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1003-1012. PubMed ID: 33387122
[TBL] [Abstract][Full Text] [Related]
27. Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.
Barstad B; Quarsten H; Tveitnes D; Noraas S; Ask IS; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29467195
[TBL] [Abstract][Full Text] [Related]
28. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
van Burgel ND; Bakels F; Kroes AC; van Dam AP
J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
[TBL] [Abstract][Full Text] [Related]
29. Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis.
Eckman EA; Clausen DM; Herdt AR; Pacheco-Quinto J; Halperin JJ
Clin Infect Dis; 2021 May; 72(10):1719-1726. PubMed ID: 32221538
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis - a prospective follow-up study.
Tjernberg I; Gyllemark P; Zetterberg H; Blennow K; Ernerudh J; Forsberg P; Sjöwall J; Henningsson AJ
Clin Chem Lab Med; 2022 Jun; 60(7):1124-1132. PubMed ID: 35499913
[TBL] [Abstract][Full Text] [Related]
31. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.
Borde JP; Meier S; Fingerle V; Klier C; Hübner J; Kern WV
BMC Infect Dis; 2012 Dec; 12():344. PubMed ID: 23228054
[TBL] [Abstract][Full Text] [Related]
32. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
[TBL] [Abstract][Full Text] [Related]
33. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.
Ziegler K; Rath A; Schoerner C; Meyer R; Bertsch T; Erbguth F; Bogdan C; Steinmann J; Held J
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32434781
[TBL] [Abstract][Full Text] [Related]
34. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis.
Fredriksson T; Brudin L; Henningsson AJ; Skogman BH; Tjernberg I
Ticks Tick Borne Dis; 2024 Jul; 15(4):102349. PubMed ID: 38723400
[TBL] [Abstract][Full Text] [Related]
36. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.
van Burgel ND; Brandenburg A; Gerritsen HJ; Kroes AC; van Dam AP
Clin Microbiol Infect; 2011 Oct; 17(10):1495-500. PubMed ID: 21375653
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
38. The NeBoP score - a clinical prediction test for evaluation of children with Lyme Neuroborreliosis in Europe.
Skogman BH; Sjöwall J; Lindgren PE
BMC Pediatr; 2015 Dec; 15():214. PubMed ID: 26678681
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study.
Stupica D; Bajrović FF; Blagus R; Cerar Kišek T; Collinet-Adler S; Lah A; Levstek E; Ružić-Sabljić E
Eur J Neurol; 2021 Sep; 28(9):3155-3166. PubMed ID: 34114701
[TBL] [Abstract][Full Text] [Related]
40. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]